Rheonix, declared that it will receive Patent Number 7,959,875, "Microfluidic Chips and Assay Systems,” from the US Patent and Trademark Office on June 14, 2011. The company has received the Patent Number 11/594,444, “Microfluidic Systems,” on April 13, 2011.
The company has developed the Rheonix CARD system to offer a strong microfluidic platform to suit the needs of the growing molecular diagnostics sector. The patents enable the company to manufacture practical diagnostic products for the commercial market.
Rheonix has several pending applications and patents throughout the world on its technology, instruments, and its applications across various fields. Using the proprietary lamination technology, the company has created a system that comprises a consumable device which uses patented microfluidic structures. The microfluidic platform offered by Rheonix uses active diaphragm valves to achieve smooth fluid movement in a single homogeneous-material device through a microfluidic network. With the help of the patented Rheonix CARD system, users can handle varied specimens in sizes varying from 10 µL to 5 mL. Rheonix uses this system at various stages of processing including raw sample preparation for use in environmental, research and clinical purposes. The company is working on products to detect infectious diseases, HPV, and for personalized medicine.
Source: http://www.rheonix.com/